These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Small cell variant type of T-prolymphocytic leukemia with a four-year indolent course preceding acute exacerbation. Shimizu D; Nomura K; Matsumoto Y; Nishida K; Taki T; Horiike S; Inaba T; Fujita N; Taniwaki M Leuk Lymphoma; 2006 Jun; 47(6):1170-2. PubMed ID: 16840216 [No Abstract] [Full Text] [Related]
29. Development of aggressive T-cell leukemia at 1 month after the diagnosis of hypereosinophilic syndrome. Yamamoto K; Doki N; Oshikawa G; Hanata N; Takizawa Y; Kubota N; Inoue M; Hagihara M; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K Leuk Lymphoma; 2014 Oct; 55(10):2402-4. PubMed ID: 24438196 [No Abstract] [Full Text] [Related]
30. Phenotypic transformation of CD52(pos) to CD52(neg) leukemic T cells as a mechanism for resistance to CAMPATH-1H. Birhiray RE; Shaw G; Guldan S; Rudolf D; Delmastro D; Santabarbara P; Brettman L Leukemia; 2002 May; 16(5):861-4. PubMed ID: 11986948 [TBL] [Abstract][Full Text] [Related]
31. A new case of Sézary cell leukemia: a morphological variant of prolymphocytic leukemia. Pérez-Vila Mf; Espinet B; Solé F; Pedro C; Woessner S; Florensa L Haematologica; 2000 Jul; 85(7):775-6. PubMed ID: 10897140 [No Abstract] [Full Text] [Related]
32. Circulating blastoid cells: acute leukemia, prolymphocytic leukemia, or something else? Zhao Y; Rehder C; Wang E Ann Hematol; 2021 Dec; 100(12):3047-3048. PubMed ID: 32929583 [No Abstract] [Full Text] [Related]
33. Complete response to alemtuzumab in a patient with B prolymphocytic leukemia. Chaar BT; Petruska PJ Am J Hematol; 2007 May; 82(5):417. PubMed ID: 17160995 [No Abstract] [Full Text] [Related]
34. B-CLL in PLL transformation associated with hypercalcemia. Lerner D; Esteves C; De Oliveira MS Leuk Lymphoma; 1994 Jan; 12(3-4):321-5. PubMed ID: 8167564 [TBL] [Abstract][Full Text] [Related]
35. Mature T-cell leukemias. Ravandi F; Kantarjian H; Jones D; Dearden C; Keating M; O'Brien S Cancer; 2005 Nov; 104(9):1808-18. PubMed ID: 16136598 [TBL] [Abstract][Full Text] [Related]
36. Improvement of quality of life after splenectomy in an HTLV-I carrier with T-cell prolymphocytic leukemia. Sakai R; Maruta A; Tomita N; Taguchi J; Fujisawa S; Ogawa K; Motomura S; Kodama F; Mohri H; Ishigatsubo Y Leuk Lymphoma; 1999 Nov; 35(5-6):607-11. PubMed ID: 10609799 [TBL] [Abstract][Full Text] [Related]
37. Sustained response of refractory prolymphocytic leukemia to fludarabine. Sporn JR Acta Haematol; 1991; 85(4):209-11. PubMed ID: 1853684 [TBL] [Abstract][Full Text] [Related]
38. [Cutaneous localization of T-cell prolymphocytic leukemia]. Thomas A; Dompmartin A; Troussard X; Moreau A; Manard C; Leroy D Ann Dermatol Venereol; 1995; 122(8):526-9. PubMed ID: 8572493 [TBL] [Abstract][Full Text] [Related]
39. The WHO classification of mature T-cell leukemias. Catovsky D; Matutes E; Dearden C; Osuji N; Brito-Babapulle V Blood; 2004 Nov; 104(9):2989-90; author reply 2990. PubMed ID: 15498862 [No Abstract] [Full Text] [Related]